Mechanism of Epigenetic Inhibitors Combined with ADC in Melanoma Treatment
Antibody drug conjugates (antibody drug conjugate, ADC) are a class of emerging targeted anti-cancer drugs that have shown excellent efficacy in clinical trials against various refractory and metastatic solid tumors. However, the therapeutic effects and potential biological mechanisms of ADC drugs used in combination with other targeted therapies remain unexplored. Recently, Researcher Guo Peng from … Read more